Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TK1 | P04183 | 5/20 | 0.65 |
| ▸ | DHFR | P00374 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6379327 | 0.92 | TK1 (0.67) | TK1DHFR | |
| SCHEMBL658884 | 0.90 | TK1 (0.65) | TK1DHFR | |
| SCHEMBL27054363 | 0.90 | TK1 (0.65) | TK1DHFRPOLB | |
| SCHEMBL7537554 | 0.90 | TK1 (0.65) | TK1DHFRPOLB | |
| SCHEMBL19308099 | 0.90 | TK1 (0.65) | TK1DHFRPOLB | |
| SCHEMBL24420522 | 0.90 | TK1 (0.65) | TK1DHFRPOLB | |
| SCHEMBL2295 | 0.89 | TK1 (0.63) | TK1DHFRPOLB | |
| SCHEMBL3272720 | 0.89 | TK1 (0.63) | TK1DHFRPOLB | |
| SCHEMBL4542151 | 0.89 | TK1 (0.63) | TK1DHFR | |
| SCHEMBL25752530 | 0.89 | TK1 (0.70) | TK1DHFRPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117512038-A | Sansansamycin derivatives and application thereof | 中国医学科学院医药生物技术研究所 | 2024-02-06 | — | — | CN | claimed |
| US-12584168-B2 | Sample preparation method | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2026-03-24 | — | — | US | disclosed |
| US-20260066042-A1 | METHODS AND SYSTEMS FOR HIGH-THROUGHPUT MOLECULAR ANALYSIS | OPENTRONS LABWORKS INC (US) | 2026-03-05 | — | — | US | disclosed |
| US-20250313889-A1 | SAMPLE PREPARATION METHOD | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2025-10-09 | — | — | US | disclosed |
| CN-117343990-B | Method and kit for determining target polynucleotide and probe set | 牛津纳米孔科技公开有限公司 | 2025-05-30 | — | — | CN | disclosed |
| CN-112703256-B | Method for determining polymer sequences | 牛津纳米孔科技公开有限公司 | 2024-09-03 | — | — | CN | disclosed |
| US-20240117337-A1 | METHODS AND POLYNUCLEOTIDES FOR AMPLIFYING A TARGET POLYNUCLEOTIDE | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2024-04-11 | — | — | US | disclosed |
| US-20240076719-A9 | METHOD | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2024-03-07 | — | — | US | disclosed |
| CN-117512038-A | Sansansamycin derivatives and application thereof | 中国医学科学院医药生物技术研究所 | 2024-02-06 | — | — | CN | disclosed |
| CN-117343990-A | Method and kit for determining target polynucleotide and probe set | 牛津纳米孔科技公开有限公司 | 2024-01-05 | — | — | CN | disclosed |
| US-6200748-B1 | OLIGONUCLEOTIDE SEQUENCES AND A TEMPLATE; FOR MONITORING AND DETECTING NUCLEOTIDE SEQUENCES; FOR THE ANALYSIS OF NUCLEIC ACIDS | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2001-03-13 | — | — | US | disclosed |
| WO-2000077179-A2 | HUMAN POLY(ADP-RIBOSE) POLYMERASE 2 MATERIALS AND METHODS | ICOS CORPORATION (US) | 2000-12-21 | — | — | WO | disclosed |
| US-5821058-A | SEPARATING PLURALITY OF POLYNUCLEOTIDES, EACH TAGGED WITH CHROMOPHORE OR FLUOROPHORE, BY ELECTROPHORESIS, DETECTING | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 1998-10-13 | — | — | US | disclosed |
| US-5552540-A | NONRADIOACTIVE LABELS | HOWARD FLOREY INSTITUTE OF EXPERIMENTAL PHYSIOLOGY AND MEDICINE (AU) | 1996-09-03 | — | — | US | disclosed |
| EP-0366685-B1 | NUCLEOSIDE DERIVATIVES | FLOREY HOWARD INST (AU) | 1994-10-19 | — | — | EP | disclosed |
| US-5171534-A | Electrophoretic analysis of DNA fragments tagged with fluorophore; absorption or fluorescent photometer | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 1992-12-15 | — | — | US | disclosed |
| EP-0366685-A4 | NUCLEOSIDE DERIVATIVES | — | 1991-03-20 | — | — | EP | disclosed |
| EP-0366685-A1 | NUCLEOSIDE DERIVATIVES. | FLOREY HOWARD INST (AU) | 1990-05-09 | — | — | EP | disclosed |
| WO-1988010264-A1 | NUCLEOSIDE DERIVATIVES | HOWARD FLOREY INSTITUTE OF EXPERIMENTAL PHYSIOLOGY (AU) | 1988-12-29 | — | — | WO | disclosed |
| US-3791928-A | PURIFICATION OF THYMIDINE KINASE | MAX PLANCK GESELLSCHAFT | 1974-02-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12584168-B2 | Sample preparation method | POLN, POLRMT, POLM | TK1 472/4885DHFR 2012/4885POLB 4/4885 |
| US-20260066042-A1 | METHODS AND SYSTEMS FOR HIGH-THROUGHPUT MOLECULAR ANALYSIS | POLRMT, POLL, SARS1 | TK1 1713/4885DHFR 2190/4885POLB 12/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.